South Korea's Financial Regulator Widens Probe of Mirae Asset After Firm Delivered Zero SpaceX IPO Shares to Clients

The Setup: A $312.5 Million Commitment That Delivered Nothing

SpaceX's IPO raised $75 billion, making it the largest public offering in history by a significant margin, according to Crypto Briefing. The company debuted at $135 per share, implying a valuation of roughly $1.76 trillion at the offer price. Shares surged 19% on their first day of trading, closing at $161.

Mirae Asset Securities wanted a piece of that for its Korean clients. The firm had pushed for a dedicated Korea tranche targeting between $1 billion and $5 billion in allocations. According to Crypto Briefing, Mirae was listed in SEC filings as having committed to purchasing 2,314,815 shares at $135 apiece, a position worth approximately $312.5 million.

Goldman Sachs, acting as lead underwriter, allocated Mirae exactly zero shares. Every subscription deposit was refunded.

What South Korea's Regulator Is Actually Investigating

South Korea's Financial Supervisory Service began its inquiry around June 14 and widened it by June 15, according to Crypto Briefing. The FSS is NOT investigating Mirae for fraud. The core question is narrower: did Mirae give investors adequate disclosure that they could walk away with nothing?

IPO allocation mechanics are, by design, opaque. Lead underwriters have broad discretion over who gets shares and who doesn't. Being named in an SEC filing as a committed buyer signals intent, not a binding contract for final delivery. A $312.5 million line item in a prospectus can evaporate at the discretion of a single underwriting desk.

A separate $500 million SpaceX offering tied to local Korean demand reportedly sold out in minutes, which suggests genuine retail appetite. That appetite, and Mirae's promotion of the opportunity, raises the disclosure question.

The Strongest Case for Mirae

Mirae's defenders have a fair point. Global institutional demand for the SpaceX IPO was overwhelming. Smaller distribution partners getting squeezed out by a massively oversubscribed deal is a routine feature of large IPOs, not evidence of misconduct. No system guarantees any firm a share allocation when books are that oversubscribed. If Mirae disclosed that IPO allocations are never guaranteed, standard language in most offering documents, the FSS may find its regulatory hook is narrow.

The question of whether Mirae specifically downplayed zero-allocation risk in its client communications, versus including the standard boilerplate, is what the FSS needs to establish.

The Real Cost to Korean Investors

Legal exposure aside, the practical damage is concrete. Korean retail investors and asset managers who were counting on IPO-price entry at $135 were forced to seek SpaceX exposure on the secondary market. Buying at $161 per share, or higher as shares continued to move after the first day, means paying at minimum a 19% premium over the price Mirae had been promoting.

On a $312.5 million notional position, the difference between $135 and $161 per share represents tens of millions of dollars in additional cost for anyone who chose to buy in anyway. Not every investor did. Some simply missed the trade entirely.

No Charges Filed; Probe Scope Still Being Defined

As of June 15, 2026, no charges have been filed against Mirae Asset Securities, and the FSS has not concluded its expanded inspection. The investigation is focused on disclosure adequacy, not fraud or market manipulation. Bloomberg News originally reported the expansion of the review, with Crypto Briefing providing additional context on the allocation mechanics and FSS scope.

The unresolved question the FSS now has to answer: what exactly did Mirae tell retail clients about zero-allocation risk before taking their subscription money, and does that language clear the bar Korean financial regulations require?